Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Hematologic Malignancies
Hematologic Malignancies for September/October 2018
Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10
Hematologic Malignancies for November/December 2017
Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al
These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al
Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al
The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al
Tyrosine Kinase Inhibitors in Pediatric ALL, Hematology 2017; 2017 Dec 8; Silverman, et al
Hematologic Malignancies for September/October 2017
NCCN Guideline Adherence Spotty in These Patients, Am J Hematol; ePub 2017 Aug 17; Goldberg, et al
Economic Burden of Auto- and Allo-HCT Evaluated, J Med Econ; ePub 2017 Aug 24; Bonafede, et al
Assessing End-of-Life Treatment in Young People, J Oncol Pract; ePub 2017 Aug 22; Johnston, et al
Look for This in Patients with ECD, Histiocytosis, Blood; 2017 Aug 24; Papo, Diamond, et al
Targeted Next-Generation Sequencing in MDS, Am J Hematol; ePub 2017 Sep 5; Tefferi, et al
Hematologic Malignancies for July/August 2017
MF Treatment Pre- and Post Ruxolitinib Approval, Clin Lymphoma Myeloma Leuk; 2017 Aug 4; Kuykendall, et al
CML-BP Outcomes in Tyrosine Kinase Inhibitor Era , Cancer; ePub 2017 Jul 25; Jain, Kantarjian, et al
Predicting Survival in Patients with Post-PV/ET, Leukemia; ePub 2017 Aug 18; Tefferi, Saeed, et al
Ruxolitinib’s Role in Ph-Like ALL , Clin Adv Hematol Oncol; 2017 Jul; Wells, et al
Building on Ruxolitinib’s Success , Clin Lymphoma Myeloma Leuk; 2017 Jul; Bose, et al
Hematologic Malignancies for May/June 2017
The Challenges of MPN Diagnosis and Risk Assessment, N Engl J Med; 2017 Jun 1; Spivak
How Post PPV and ET Differ from Primary Myelofibrosis , Leuk Res; 2017 Jun 2; Masarova, Bose, Daver et al
Timing of Antibiotic Administration for Neutropenic Fever, J Oncol Pharm Pract; 2017 Jun; Butts, et al
Tyrosine Kinase Inhibitors in Patients with AML, Stem Cell Investig; 2017 Jun 2; Chen, Pan, et al
Online Yoga Intervention in MPN Patients Evaluated, Haematologica; ePub 2017 Jun 8; Huberty, et al